How many 8-K filings has Envveno Medical Corp filed?

Envveno Medical Corp (NVNO) has 12 8-K (Current Event Report) filings on record, spanning Mar 2024 to Dec 2025.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Envveno Medical Corp 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Envveno Medical Corp 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Envveno Medical Corp (NVNO) — 8-K Filings

All 8-K filings from Envveno Medical Corp. Browse 12 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (12)

enVVeno Medical Corp. Files 8-K on Shareholder Vote & Financials — Dec 12, 2025 Risk: low
On December 11, 2025, enVVeno Medical Corp. filed an 8-K report detailing the submission of matters to a vote of security holders and financial statements. The
enVVeno Medical Corp Files 8-K for Bylaws and Financials — Nov 20, 2025 Risk: low
On November 17, 2025, enVVeno Medical Corporation filed an 8-K report detailing amendments to its Articles of Incorporation and Bylaws. The filing also included
enVVeno Medical Corp Files 8-K — Nov 14, 2025 Risk: low
On November 13, 2025, enVVeno Medical Corporation filed an 8-K report detailing a Regulation FD Disclosure and Financial Statements and Exhibits. The company, f
enVVeno Medical Corp. Files 8-K with Material Agreement — Oct 30, 2025 Risk: medium
On October 30, 2025, enVVeno Medical Corp. filed an 8-K report. The filing indicates an entry into a material definitive agreement and includes financial statem
enVVeno Medical Corp. Files 8-K on Delisting Concerns — Oct 10, 2025 Risk: high
enVVeno Medical Corporation (formerly Hancock Jaffe Laboratories, Inc.) filed an 8-K on October 10, 2025, reporting a notice of delisting or failure to satisfy
enVVeno Medical Corp. Files 8-K Report — Aug 20, 2025 Risk: low
On August 20, 2025, enVVeno Medical Corp. filed an 8-K report. The filing primarily concerns Regulation FD disclosures and the submission of financial statement
enVVeno Medical Corp Reports Director/Officer Changes — May 20, 2025 Risk: medium
On May 19, 2025, enVVeno Medical Corporation (formerly Hancock Jaffe Laboratories, Inc.) filed an 8-K report. The filing indicates changes related to the depart
enVVeno Medical Corp Changes Certifying Accountant — Apr 21, 2025 Risk: low
On April 17, 2025, enVVeno Medical Corporation (formerly Hancock Jaffe Laboratories, Inc.) filed an 8-K report. The filing indicates a change in the registrant'
enVVeno Medical Corp. Approves 1-for-15 Reverse Stock Split — Dec 26, 2024 Risk: medium
On December 18, 2024, enVVeno Medical Corporation filed an 8-K to report that its Board of Directors approved a reverse stock split of its common stock at a rat
enVVeno Medical Corp. Signs Material Definitive Agreement — Sep 30, 2024 Risk: medium
On September 26, 2024, enVVeno Medical Corp. entered into a material definitive agreement. The company, formerly known as Hancock Jaffe Laboratories, Inc., is i
enVVeno Medical Corp Files 8-K — Apr 24, 2024 Risk: low
On April 24, 2024, enVVeno Medical Corporation filed an 8-K report. The filing primarily concerns financial statements and exhibits, and a Regulation FD Disclos
enVVeno Medical Corp. Files 8-K Report — Mar 6, 2024 Risk: low
On March 6, 2024, enVVeno Medical Corp. (formerly Hancock Jaffe Laboratories, Inc.) filed an 8-K report. The filing primarily concerns Regulation FD Disclosure

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX